GIPR expression varies in adrenal and pituitary tumors, and neuroendocrine tumors, but - regardless of the tumor’s type and origin, cAMP signaling is activated in all GIPR-positive tumors and not in GIPR-negative ones [101]. The gene discussed is GIPR; the disease is neoplasm.